SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Severi G) "

Sökning: WFRF:(Severi G)

  • Resultat 31-40 av 178
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
31.
  •  
32.
  •  
33.
  •  
34.
  • Hollestelle, Antoinette, et al. (författare)
  • No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
  • 2016
  • Ingår i: Gynecologic Oncology. - : Elsevier BV. - 0090-8258 .- 1095-6859. ; 141:2, s. 386-401
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective Clinical genetic testing is commercially available for rs61764370, an inherited variant residing in a KRAS 3′ UTR microRNA binding site, based on suggested associations with increased ovarian and breast cancer risk as well as with survival time. However, prior studies, emphasizing particular subgroups, were relatively small. Therefore, we comprehensively evaluated ovarian and breast cancer risks as well as clinical outcome associated with rs61764370. Methods Centralized genotyping and analysis were performed for 140,012 women enrolled in the Ovarian Cancer Association Consortium (15,357 ovarian cancer patients; 30,816 controls), the Breast Cancer Association Consortium (33,530 breast cancer patients; 37,640 controls), and the Consortium of Modifiers of BRCA1 and BRCA2 (14,765 BRCA1 and 7904 BRCA2 mutation carriers). Results We found no association with risk of ovarian cancer (OR = 0.99, 95% CI 0.94-1.04, p = 0.74) or breast cancer (OR = 0.98, 95% CI 0.94-1.01, p = 0.19) and results were consistent among mutation carriers (BRCA1, ovarian cancer HR = 1.09, 95% CI 0.97-1.23, p = 0.14, breast cancer HR = 1.04, 95% CI 0.97-1.12, p = 0.27; BRCA2, ovarian cancer HR = 0.89, 95% CI 0.71-1.13, p = 0.34, breast cancer HR = 1.06, 95% CI 0.94-1.19, p = 0.35). Null results were also obtained for associations with overall survival following ovarian cancer (HR = 0.94, 95% CI 0.83-1.07, p = 0.38), breast cancer (HR = 0.96, 95% CI 0.87-1.06, p = 0.38), and all other previously-reported associations. Conclusions rs61764370 is not associated with risk of ovarian or breast cancer nor with clinical outcome for patients with these cancers. Therefore, genotyping this variant has no clinical utility related to the prediction or management of these cancers.
  •  
35.
  • Laskar, Ruhina S, et al. (författare)
  • Sex specific associations in genome wide association analysis of renal cell carcinoma.
  • 2019
  • Ingår i: European Journal of Human Genetics. - : Springer Science and Business Media LLC. - 1018-4813 .- 1476-5438. ; 27:10, s. 1589-1598
  • Tidskriftsartikel (refereegranskat)abstract
    • Renal cell carcinoma (RCC) has an undisputed genetic component and a stable 2:1 male to female sex ratio in its incidence across populations, suggesting possible sexual dimorphism in its genetic susceptibility. We conducted the first sex-specific genome-wide association analysis of RCC for men (3227 cases, 4916 controls) and women (1992 cases, 3095 controls) of European ancestry from two RCC genome-wide scans and replicated the top findings using an additional series of men (2261 cases, 5852 controls) and women (1399 cases, 1575 controls) from two independent cohorts of European origin. Our study confirmed sex-specific associations for two known RCC risk loci at 14q24.2 (DPF3) and 2p21(EPAS1). We also identified two additional suggestive male-specific loci at 6q24.3 (SAMD5, male odds ratio (ORmale) = 0.83 [95% CI = 0.78-0.89], Pmale = 1.71 × 10-8 compared with female odds ratio (ORfemale) = 0.98 [95% CI = 0.90-1.07], Pfemale = 0.68) and 12q23.3 (intergenic, ORmale = 0.75 [95% CI = 0.68-0.83], Pmale = 1.59 × 10-8 compared with ORfemale = 0.93 [95% CI = 0.82-1.06], Pfemale = 0.21) that attained genome-wide significance in the joint meta-analysis. Herein, we provide evidence of sex-specific associations in RCC genetic susceptibility and advocate the necessity of larger genetic and genomic studies to unravel the endogenous causes of sex bias in sexually dimorphic traits and diseases like RCC.
  •  
36.
  •  
37.
  •  
38.
  •  
39.
  •  
40.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 31-40 av 178
Typ av publikation
tidskriftsartikel (170)
konferensbidrag (7)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (168)
övrigt vetenskapligt/konstnärligt (10)
Författare/redaktör
Severi, G (84)
Severi, Gianluca (79)
Giles, Graham G (57)
Giles, GG (44)
Easton, DF (41)
Baglietto, L (40)
visa fler...
Southey, MC (39)
Hall, P (37)
Chang-Claude, J (37)
Albanes, Demetrius (36)
Hopper, JL (36)
Fasching, PA (35)
Beckmann, MW (35)
Garcia-Closas, M (33)
Ekici, AB (32)
Cox, A (32)
Couch, FJ (32)
Lissowska, J (32)
Chenevix-Trench, G (32)
Milne, RL (31)
Nordestgaard, BG (31)
Nevanlinna, H (31)
Dunning, AM (30)
Mannermaa, A (30)
Kosma, VM (30)
Czene, K (29)
Anton-Culver, H (29)
Chanock, Stephen J (29)
Bojesen, SE (29)
Kataja, V (29)
Brauch, H (28)
Pharoah, PDP (28)
Johansson, Mattias (28)
Benitez, J. (27)
Riboli, Elio (27)
Dork, T (27)
Kraft, Peter (27)
Le Marchand, Loïc (27)
Lindblom, A (26)
Schmidt, MK (26)
Peto, J (26)
Lambrechts, D (26)
Margolin, S (25)
Flesch-Janys, D (25)
Chanock, SJ (25)
Brenner, H (24)
Blomqvist, C (24)
Weiderpass, Elisabet ... (24)
Zheng, Wei (24)
Ziogas, A (24)
visa färre...
Lärosäte
Karolinska Institutet (128)
Umeå universitet (77)
Lunds universitet (33)
Uppsala universitet (27)
Göteborgs universitet (3)
Stockholms universitet (3)
visa fler...
Högskolan Kristianstad (1)
Linköpings universitet (1)
Handelshögskolan i Stockholm (1)
Chalmers tekniska högskola (1)
visa färre...
Språk
Engelska (177)
Odefinierat språk (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (89)
Naturvetenskap (2)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy